Business
Summit Therapeutics Inc: Why Investors Shouldn’t Get Rid Of SMMT Stock In 2025
In the last trading session, 2.22 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.95. Most recently the company’s